Literature DB >> 9811533

Cytokine production by human peripheral blood mononuclear cells: differential senstivity to glutamine availability.

P Yaqoob1, P C Calder.   

Abstract

Human peripheral blood mononuclear cells (PBMCs) were cultured in the presence of different glutamine concentrations (0, 0.1, 0.4, 0.6, 2 mM) and stimulated with concanavalin A (Con A) or bacterial lipopolysaccharide (LPS). The concentrations of T lymphocyte- and monocyte-derived cytokines were measured in the culture medium 24 h later. The availability of glutamine significantly increased the production of interleukin (IL)-2 (2-fold), IL-10 (4-fold) and interferon (IFN)-gamma (4.5-fold) by Con A-stimulated PBMCs. Maximal production of these cytokines occurred at 0.1 mM glutamine and increasing the concentration of glutamine above that did not lead to a further increase in cytokine production. Glutamine availability resulted in small increases (24 to 35%) in the production of IL-1alpha, IL-1beta, IL-6 and tumour necrosis factor (TNF)-alpha by Con A-stimulated PBMCs; again maximal production occurred at a glutamine concentration of 0.1 mM. Glutamine availability did not influence the production of IL-1beta or TNF-alpha by LPS-stimulated PBMCs, while there was a small increase (17 to 32%) in the production of IL-1alpha, IL-6 and IL-10 by these cells at a glutamine concentration of 0.1 mM. It is concluded that glutamine enhances the production of T lymphocyte-derived cytokines with only minimal effects on production of cytokines by monocytes. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811533     DOI: 10.1006/cyto.1998.0358

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  15 in total

1.  Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation.

Authors:  Erikka L Carr; Alina Kelman; Glendon S Wu; Ravindra Gopaul; Emilee Senkevitch; Anahit Aghvanyan; Achmed M Turay; Kenneth A Frauwirth
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

2.  The effects of acute oral glutamine supplementation on exercise-induced gastrointestinal permeability and heat shock protein expression in peripheral blood mononuclear cells.

Authors:  Micah Zuhl; Karol Dokladny; Christine Mermier; Suzanne Schneider; Roy Salgado; Pope Moseley
Journal:  Cell Stress Chaperones       Date:  2014-07-26       Impact factor: 3.667

3.  Glutamine depletion potentiates leucocyte-dependent inflammatory events induced by carrageenan or Clostridium difficile toxin A in rats.

Authors:  Silvia B Nascimento; Romualdo B Sousa; Marcos Jullian B Martins; Antoniella Souza Gomes; Marcellus Henrique L P Souza; Richard L Guerrant; Fernando Q Cunha; Ronaldo A Ribeiro; Gerly A C Brito
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

Review 4.  Glutamine supplementation in vitro and in vivo, in exercise and in immunodepression.

Authors:  Linda Castell
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  System A amino acid transporters regulate glutamine uptake and attenuate antibody-mediated arthritis.

Authors:  Bruno Raposo; Daniëlle Vaartjes; Emma Ahlqvist; Kutty-Selva Nandakumar; Rikard Holmdahl
Journal:  Immunology       Date:  2015-10-05       Impact factor: 7.397

6.  Does Branched-Chain Amino Acids Supplementation Modulate Skeletal Muscle Remodeling through Inflammation Modulation? Possible Mechanisms of Action.

Authors:  Humberto Nicastro; Claudia Ribeiro da Luz; Daniela Fojo Seixas Chaves; Luiz Roberto Grassmann Bechara; Vanessa Azevedo Voltarelli; Marcelo Macedo Rogero; Antonio Herbert Lancha
Journal:  J Nutr Metab       Date:  2012-02-14

Review 7.  Factors influencing the eicosanoids synthesis in vivo.

Authors:  Jarosław Szefel; Wiesław Janusz Kruszewski; Ewa Sobczak
Journal:  Biomed Res Int       Date:  2015-03-11       Impact factor: 3.411

8.  Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials.

Authors:  Kai Kang; Xiao-Liang Shu; Yong-Sheng Zhang; Xian-Li Liu; Jian Zhao
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

9.  Activated lymphocytes as a metabolic model for carcinogenesis.

Authors:  Andrew N Macintyre; Jeffrey C Rathmell
Journal:  Cancer Metab       Date:  2013-01-23

10.  Peptides from Colochirus robustus Enhance Immune Function via Activating CD3ζ- and ZAP-70-Mediated Signaling in C57BL/6 Mice.

Authors:  Xiaogang Du; Fangliang Lian; Yunkun Li; Dong Li; Dayong Wu; Qunli Feng; Zhijiang Feng; Yun Li; Guixian Bu; Fengyan Meng; Xiaohan Cao; Zhiyu Chen; Xianyin Zeng
Journal:  Int J Mol Sci       Date:  2017-10-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.